Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
CYTIWMPENPRPGTPCDIFTNSRGKRASNG-peg-DMG
CYTIWMPENPRPGTPCDIFTNSRGKRASNG-peg-DMG
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-M2-10092 | 50mg | inquiry | ||
|
|
||||
Product description
The core sequence of CYTIWMPENPRPGTPCDIFTNSRGKRASNG peg DMG is derived from the rabies virus glycoprotein (RVG29) and has the ability to penetrate the blood-brain barrier (BBB). PEGylation can enhance its water solubility and stability, while DMG modification may be used to improve drug delivery properties or bind to specific targets. This peptide is mainly used for targeted therapy of brain diseases, such as drug delivery for neurodegenerative diseases or brain tumors.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Solubility | N/A |
| Molecular formula | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 1-3 weeks |
| Stability | 1 year |
Document
msds of CYTIWMPENPRPGTPCDIFTNSRGKRASNG-peg-DMG Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
